Purchase Order 36C24825P0732

Award Date 2/18/25
Potential Completion Date 2/28/25
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fresno, CA 93727, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the provision of Novocure Inc.'s Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $45,600.00 firm fixed-price Purchase Order was awarded to the prime contractor Novocure Inc., a foreign-owned, for-profit medical device manufacturer, on August 27, 2024, with a completion date of January 13,...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract (Award ID: 36C26223P0309), with a ceiling value of $16,582.91, is a Firm Fixed Price Purchase Order placed under...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune device, a specialized cancer therapy technology utilizing Tumor Treating Fields (TTFields). The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order with a completion date of July 16, 2025. Novocure holds a significant...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of TFH 9000 OPTUNE PLUS TRANSDUCERS for the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $84,000.00 firm fixed-price purchase order, awarded on June 29, 2020, has an ultimate completion date of December 29, 2020. The contract does not utilize any set-aside designations. Novocure is the prime contractor and is delivering its...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducer devices and associated support services. The $33,165.82 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022. This contract enables the VA to efficiently...
This federal contract award is for the provision of Novocure Inc.'s Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $49,748.73 and is a Firm Fixed Price Purchase Order with a period of performance through March 6, 2025. Novocure, a foreign-owned, for-profit manufacturer of medical devices,...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The $49,748.73 firm-fixed-price delivery order is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune system, a cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) for the delivery of Optune medical devices, transducer arrays, rental...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...

This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The contract does not utilize any set-aside designations. Novocure acts as the prime contractor, delivering its proprietary cancer treatment technologies directly to VA medical facilities nationwide. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined procurement vehicle for the VA to obtain Novocure's innovative Optune TTFields therapy products and services to support the agency's mission of expanding veterans' access to cutting-edge cancer treatments.

Generated 2/21/25, 10:04 AM